Yongchao Su

Yongchao Su is a Senior Principal Scientist at Merck since August 2014, specializing in Discovery Pharmaceutical Sciences. Key contributions include leadership in high-concentration biologics and development of small molecule drugs, with several patent applications filed. Su also serves as Editor-in-Chief for AAPS Open at Springer Nature Group, beginning January 2024. Prior to these roles, experience includes postdoctoral research at the Massachusetts Institute of Technology focused on protein misfolding in amyloid diseases, and graduate research at Iowa State University on peptide permeation. Educational background encompasses a Ph.D. from Iowa State University and a postdoctoral degree from MIT, as well as advanced studies in physics and chemistry at various institutions in China.